ALCRB Fundamental Analysis - CARBIOS

Fundamental Rating

Taking everything into account, ALCRB scores 3 out of 10 in our fundamental rating. ALCRB was compared to 69 industry peers in the Chemicals industry. The financial health of ALCRB is average, but there are quite some concerns on its profitability. ALCRB is quite expensive at the moment. It does show a decent growth rate.

Quickly go to:

1. Profitability

1.1 Basic Checks

ALCRB had negative earnings in the past year.

ALCRB had a negative operating cash flow in the past year.

ALCRB had negative earnings in 4 of the past 5 years.

In the past 5 years ALCRB always reported negative operating cash flow.

1.2 Ratios

ALCRB has a Return On Assets of -16.01%. This is amonst the worse of the industry: ALCRB underperforms 81.16% of its industry peers.

ALCRB has a worse Return On Equity (-21.99%) than 81.16% of its industry peers.

		Industry Rank	Sector Rank
ROA	-16.01%
ROE	-21.99%
ROIC	N/A

ROA(3y)-11.97%

ROA(5y)-10.26%

ROE(3y)-16.77%

ROE(5y)-14.67%

ROIC(3y)N/A

ROIC(5y)N/A

1.3 Margins

ALCRB does not have Profit Margin and Operating Margin and Gross Margin available, so we won't be analyzing them here.

		Industry Rank	Sector Rank
OM	N/A
PM (TTM)	N/A
GM	N/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

More info and screens

ROA

ROE

ROIC

Operating and Profit Margin

Show most profitable peers

2. Health

2.1 Basic Checks

ALCRB does not have a ROIC to compare to the WACC, probably because it is not profitable.

ALCRB has about the same amout of shares outstanding than it did 1 year ago.

The number of shares outstanding for ALCRB has been increased compared to 5 years ago.

The debt/assets ratio for ALCRB has remained at the same level compared to a year ago.

2.2 Solvency

Based on the Altman-Z score of 0.82, we must say that ALCRB is in the distress zone and has some risk of bankruptcy.

With a Altman-Z score value of 0.82, ALCRB is not doing good in the industry: 82.61% of the companies in the same industry are doing better.

ALCRB has a Debt/Equity ratio of 0.19. This is a healthy value indicating a solid balance between debt and equity.

Looking at the Debt to Equity ratio, with a value of 0.19, ALCRB is in the better half of the industry, outperforming 71.01% of the companies in the same industry.

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Altman-Z	0.82

ROIC/WACCN/A

WACC7.3%

2.3 Liquidity

A Current Ratio of 3.84 indicates that ALCRB has no problem at all paying its short term obligations.

With an excellent Current ratio value of 3.84, ALCRB belongs to the best of the industry, outperforming 94.20% of the companies in the same industry.

ALCRB has a Quick Ratio of 3.79. This indicates that ALCRB is financially healthy and has no problem in meeting its short term obligations.

ALCRB has a Quick ratio of 3.79. This is amongst the best in the industry. ALCRB outperforms 97.10% of its industry peers.

		Industry Rank	Sector Rank
Current Ratio	3.84
Quick Ratio	3.79

More info and screens

WACC

Debt/Equity

How to determine the health of a company

Altman-Z score

Show peers with great health

3. Growth

3.1 Past

The earnings per share for ALCRB have decreased strongly by -17.78% in the last year.

The Revenue has grown by 655.84% in the past year. This is a very strong growth!

The Revenue for ALCRB have been decreasing by -37.71% on average. This is quite bad

EPS 1Y (TTM)-17.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-30.12%

Revenue 1Y (TTM)655.84%

Revenue growth 3Y9.01%

Revenue growth 5Y-37.71%

Sales Q2Q%610.96%

3.2 Future

Based on estimates for the next years, ALCRB will show a very strong growth in Earnings Per Share. The EPS will grow by 27.01% on average per year.

ALCRB is expected to show a strong growth in Revenue. In the coming years, the Revenue will grow by 300.17% yearly.

EPS Next Y2.78%

EPS Next 2Y8.43%

EPS Next 3Y5.34%

EPS Next 5Y27.01%

Revenue Next Year108.33%

Revenue Next 2Y400%

Revenue Next 3Y364.16%

Revenue Next 5Y300.17%

3.3 Evolution

When comparing the Revenue growth rate of the last years to the growth rate of the upcoming years, we see that the growth is accelerating.

More info and screens

Find the best growth stocks

Show best growing peers

4. Valuation

4.1 Price/Earnings Ratio

The Price/Earnings Ratio is negative for ALCRB. In the last year negative earnings were reported.

Besides the negative Price/Earnings Ratio, also the Forward Price/Earnings Ratio is negative for ALCRB. No positive earnings are expected for the next year.

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A

4.2 Price Multiples

		Industry Rank	Sector Rank
P/FCF	N/A
EV/EBITDA	N/A

4.3 Compensation for Growth

PEG (NY)N/A

PEG (5Y)N/A

EPS Next 2Y8.43%

EPS Next 3Y5.34%

More info and screens

Show best valued peers

5. Dividend

5.1 Amount

ALCRB does not give a dividend.

		Industry Rank	Sector Rank
Dividend Yield	0%

More info and screens

Find the best dividend stocks

Show peers with best dividend

CARBIOS

EPA:ALCRB (1/9/2026, 7:00:00 PM)

11.14

+0.29 (+2.67%)

Chartmill FA Rating

GICS SectorMaterials

GICS IndustryGroupMaterials

GICS IndustryChemicals

Earnings (Last)09-24 2025-09-24

Earnings (Next)04-09 2026-04-09

Inst Owners16.94%

Inst Owner ChangeN/A

Ins OwnersN/A

Ins Owner ChangeN/A

Market Cap188.38M

Revenue(TTM)582.00K

Net Income(TTM)-38.57M

Analysts84

Price Target13.26 (19.03%)

Short Float %N/A

Short RatioN/A

Dividend

		Industry Rank	Sector Rank
Dividend Yield	0%

Yearly DividendN/A

Dividend Growth(5Y)N/A

DPN/A

Div Incr Years0

Div Non Decr Years0

Ex-DateN/A

Surprises & Revisions

EPS beat(2)N/A

Avg EPS beat(2)N/A

Min EPS beat(2)N/A

Max EPS beat(2)N/A

EPS beat(4)N/A

Avg EPS beat(4)N/A

Min EPS beat(4)N/A

Max EPS beat(4)N/A

EPS beat(8)N/A

Avg EPS beat(8)N/A

EPS beat(12)N/A

Avg EPS beat(12)N/A

EPS beat(16)N/A

Avg EPS beat(16)N/A

Revenue beat(2)N/A

Avg Revenue beat(2)N/A

Min Revenue beat(2)N/A

Max Revenue beat(2)N/A

Revenue beat(4)N/A

Avg Revenue beat(4)N/A

Min Revenue beat(4)N/A

Max Revenue beat(4)N/A

Revenue beat(8)N/A

Avg Revenue beat(8)N/A

Revenue beat(12)N/A

Avg Revenue beat(12)N/A

Revenue beat(16)N/A

Avg Revenue beat(16)N/A

PT rev (1m)0%

PT rev (3m)18.18%

EPS NQ rev (1m)N/A

EPS NQ rev (3m)N/A

EPS NY rev (1m)0%

EPS NY rev (3m)0%

Revenue NQ rev (1m)N/A

Revenue NQ rev (3m)N/A

Revenue NY rev (1m)0%

Revenue NY rev (3m)0%

Valuation

		Industry Rank	Sector Rank
PE	N/A
Fwd PE	N/A
P/S	323.67
P/FCF	N/A
P/OCF	N/A
P/B	1.07
P/tB	1.41
EV/EBITDA	N/A

EPS(TTM)-2.29

EYN/A

EPS(NY)-1.86

Fwd EYN/A

FCF(TTM)-3.7

FCFYN/A

OCF(TTM)-1.79

OCFYN/A

SpS0.03

BVpS10.37

TBVpS7.9

PEG (NY)N/A

PEG (5Y)N/A

Graham NumberN/A

Profitability

		Industry Rank	Sector Rank
ROA	-16.01%
ROE	-21.99%
ROCE	N/A
ROIC	N/A
ROICexc	N/A
ROICexgc	N/A
OM	N/A
PM (TTM)	N/A
GM	N/A
FCFM	N/A

ROA(3y)-11.97%

ROA(5y)-10.26%

ROE(3y)-16.77%

ROE(5y)-14.67%

ROIC(3y)N/A

ROIC(5y)N/A

ROICexc(3y)N/A

ROICexc(5y)N/A

ROICexgc(3y)N/A

ROICexgc(5y)N/A

ROCE(3y)N/A

ROCE(5y)N/A

ROICexgc growth 3YN/A

ROICexgc growth 5YN/A

ROICexc growth 3YN/A

ROICexc growth 5YN/A

OM growth 3YN/A

OM growth 5YN/A

PM growth 3YN/A

PM growth 5YN/A

GM growth 3YN/A

GM growth 5YN/A

F-Score3

Asset Turnover0

Health

		Industry Rank	Sector Rank
Debt/Equity	0.19
Debt/FCF	N/A
Debt/EBITDA	N/A
Cap/Depr	213.71%
Cap/Sales	5553.26%
Interest Coverage	N/A
Cash Conversion	N/A
Profit Quality	N/A
Current Ratio	3.84
Quick Ratio	3.79
Altman-Z	0.82

F-Score3

WACC7.3%

ROIC/WACCN/A

Cap/Depr(3y)437.01%

Cap/Depr(5y)449.88%

Cap/Sales(3y)53289.6%

Cap/Sales(5y)34828.7%

Profit Quality(3y)N/A

Profit Quality(5y)N/A

High Growth Momentum

Growth

EPS 1Y (TTM)-17.78%

EPS 3YN/A

EPS 5YN/A

EPS Q2Q%-30.12%

EPS Next Y2.78%

EPS Next 2Y8.43%

EPS Next 3Y5.34%

EPS Next 5Y27.01%

Revenue 1Y (TTM)655.84%

Revenue growth 3Y9.01%

Revenue growth 5Y-37.71%

Sales Q2Q%610.96%

Revenue Next Year108.33%

Revenue Next 2Y400%

Revenue Next 3Y364.16%

Revenue Next 5Y300.17%

EBIT growth 1Y-17.73%

EBIT growth 3YN/A

EBIT growth 5YN/A

EBIT Next Year34.55%

EBIT Next 3Y15.43%

EBIT Next 5Y34.22%

FCF growth 1Y-48.7%

FCF growth 3YN/A

FCF growth 5YN/A

OCF growth 1Y-5.97%

OCF growth 3YN/A

OCF growth 5YN/A

CARBIOS / ALCRB.PA FAQ

What is the fundamental rating for ALCRB stock?

ChartMill assigns a fundamental rating of 3 / 10 to ALCRB.PA.

What is the valuation status for ALCRB stock?

ChartMill assigns a valuation rating of 0 / 10 to CARBIOS (ALCRB.PA). This can be considered as Overvalued.

How profitable is CARBIOS (ALCRB.PA) stock?

CARBIOS (ALCRB.PA) has a profitability rating of 0 / 10.

What is the expected EPS growth for CARBIOS (ALCRB.PA) stock?

The Earnings per Share (EPS) of CARBIOS (ALCRB.PA) is expected to grow by 2.78% in the next year.

CARBIOS (ALCRB.PA) Stock Fundamental Analysis

1. Profitability

1.1 Basic Checks

1.2 Ratios

1.3 Margins

More info and screens

2. Health

2.1 Basic Checks

2.2 Solvency

2.3 Liquidity

More info and screens

3. Growth

3.1 Past

3.2 Future

3.3 Evolution

More info and screens

4. Valuation

4.1 Price/Earnings Ratio

4.2 Price Multiples

4.3 Compensation for Growth

More info and screens

5. Dividend

5.1 Amount

More info and screens

CARBIOS / ALCRB.PA FAQ

What is the fundamental rating for ALCRB stock?

What is the valuation status for ALCRB stock?

How profitable is CARBIOS (ALCRB.PA) stock?

What is the expected EPS growth for CARBIOS (ALCRB.PA) stock?